Actions of cis-diamminedichloroplatinum on cell surface nucleic acids in cancer cells as determined by cell electrophoresis techniques.
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D002462:Cell Membrane / Q000032:analysis / Q000378:metabolism; D002945:Cisplatin / Q000494:pharmacology*; D004247:DNA / Q000276:immunology; D004262:DNA Restriction Enzymes / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000032:analysis*; D003851:Deoxyribonucleases / Q000378:metabolism; D004586:Electrophoresis; D007106:Immune Sera; D007526:Isoelectric Point; D007700:Kinetics; D051379:Mice; D009944:Organoplatinum Compounds / Q000378:metabolism; D012334:RNA, Neoplasm / Q000032:analysis*; D012260:Ribonucleases / Q000378:metabolism; D012510:Sarcoma 180 / Q000032:analysis*; D013499:Surface Properties
D000963:Antimetabolites; D004273:DNA, Neoplasm; D007106:Immune Sera; D009944:Organoplatinum Compounds; D012334:RNA, Neoplasm; C023360:platinum thymine blue; D004247:DNA; D003851:Deoxyribonucleases; D012260:Ribonucleases; D004262:DNA Restriction Enzymes; D002945:Cisplatin